Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.

from NDTV Profit-Latest https://ift.tt/4PrSugy
via xxx

Comments

Popular posts from this blog

Opinion: North-South Divide Risky Strategy For Congress In 2024

Bureaucrat Shares Video Of Twin Sisters Not Recognising Father After He Shaves Beard